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Abstract
Leukotriene D4 (LTD4) is a pro-inflammatory mediator formed from arachi-
donic acid through the action of 5-lipoxygenase (5-LOX). Its biological effects
are mediated by at least two G-coupled plasmatic cysteinyl LT receptors (Cys-
LT1-2R). It has been reported an upregulation of the 5-LOX pathway in tumor
tissue unlike in normal colon mucosa. Colon tumors generally have an
increased expression of CysLT1R and colon cancer patients with high expres-
sion levels of CysLT1R have poor prognosis. We previously observed that the
cyclooxygenase pathway is involved in the control of intestinal epithelial can-
cer cell growth through PGE2 production. The aim of this study was therefore
to assess the effect of LTD4 binding with CysLT1R on Caco-2 cell growth. We
note a number of key findings from this research. We observed that at a con-
centration similar to that found under inflammatory conditions, LTD4 was
able to induce Caco-2 cell proliferation and DNA synthesis. Moreover, with
the use of a specific receptor antagonist this study has demonstrated that the
effect of LTD4 is a result of its interaction with CystLT1R. We also note the
possible participation of the PLC-IP3-Ca
2+/DAG-PKC signaling pathways in
cytosolic PLA2 and [
3H]AA release induced by LTD4-CystLT1R interaction.
Finally, we found that the resulting activation of the AA cascade and the pro-
duction of PGE2 eicosanoid could be related to the activation of cell signaling
pathways such as ERK and CREB. These findings will help facilitate our
understanding of how inflammatory mediators can affect the survival and dis-
semination of intestinal carcinoma cells.
Introduction
Leukotriene D4 (LTD4) is a powerful pro-inflammatory
mediator, which is formed from arachidonic acid through
the action of 5-lipoxygenase (5-LOX) (Samuelsson 1979).
LTD4 mediates its effects through specific cell surface
receptors that belong to the G protein-coupled receptor
family, cysteinyl leukotriene receptors (CysLTR). Two
such receptors have previously been cloned: CysLT1R
(Lynch et al. 1999) and CysLT2R (Heise et al. 2000). Cys-
LT1R has the highest affinity of the two receptors (Heise
et al. 2000). As such it has a higher affinity for LTD4 than
CysLT2R (Lynch et al. 1999).
LTD4 is associated with the pathogenesis of several
inflammatory disorders such as inflammatory bowel
disease (IBD) (Stenton 1990). Not only is there a well-
established connection between IBD and increased fre-
quency of neoplastic transformation (Smalley and Dubois
1997), but a more general link between chronic inflam-
mation and an increased risk of developing cancer has
been suggested in previous studies (Coussens and Werb
2002). A cause-and-effect link has been established
between chronic inflammation and colon cancer, which
occurs via the activation and over-expression of the
enzymes 5-LOX and cyclooxygenase-2 (COX-2). These
enzymes are responsible for regulating the production of
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LTs and prostaglandins (PGs), respectively (Coussens and
Werb 2002; Qiao and Li 2014). Unlike non-transformed
human epithelial cells, CysLT2R is downregulated in the
colon cancer cell lines (Magnusson et al. 2007). In con-
trast, it has been demonstrated that CysLT1R is upregulat-
ed in colon cancer tissue and that the binding of LTD4 to
this receptor facilitates the survival of the cells in this tis-
sue and negatively correlates with patient survival (€Ohd
et al. 2000, 2003). In accordance with this trend, Magnus-
son et al. (2007, 2010) recently observed that colon can-
cer patients with high expression levels of CysLT1R
exhibited a poor prognosis. Moreover, as noted by Yudi-
na et al. (2008), LTD4 upregulates 5-LOX, COX-2, and
CysLT1R levels in intestinal epithelial cells providing a
mechanism for maintaining inflammation and tumor
progression.
In our study, we observed that through CysLT1R bind-
ing, LTD4 increases the release of arachidonic acid (AA)
and the synthesis of PGE2. In addition, we found that this
prostaglandin is responsible for the proliferative effects
induced by LTD4 on intestinal epithelial Caco-2 cells.
Materials and Methods
Materials
LTD4, PGE2 and murine COX-2 were purchased from
Cayman Chemical (Ann Arbor, MI). Non-essential amino
acids, FBS, BSA, Fura-2 acetoxymethylester (Fura-2 AM),
U73122, dantrolene, G€o 6983, ketoprofen, LY 171883,
MK 571, NS 398, SC560 and SC19220, PD98059, ethidi-
um bromide and acridine orange were purchased from
Sigma Chemical (St. Louis, MO). LY 255283 was pur-
chased from Tocris Biosc. (Bristol, UK). Arachidonyl tri-
fluoromethylketone (AACOCF3) and bromoenol lactone
(BEL) were acquired from Alexis Corp. (San Diego, CA).
[Methyl-3H]thymidine (20 Ci/mmol) and [5,6,8,9,11,12,-
14,15-3H] arachidonic acid ([3H]AA) (60-100 Ci/mmol)
were from American Radiolabeled Chemicals Inc. (St.
Louis, MO), and AH 23838 was kindly provided by
Glaxo-Wellcome (Stevenage, UK).
Cell culture and cell growth assay
Caco-2 cells, derived from a colon adenocarcinoma, were
provided by the American Type Culture Collection
(HTB-37, Manassas, VA). The cells were routinely grown
in plastic flasks at a density of 104 cells/cm2 and cultured
in DMEM supplemented with 4.5 g/L D-glucose, 1% (v/
v) nonessential amino acids, 2 mmol/L L-glutamine, 10%
(v/v) heat-inactivated FBS, 100 U/mL penicillin and
0.1 mg/mL streptomycin at 37C in a modified atmo-
sphere of 5% CO2 in air, as previously described (Martın-
Venegas et al. 2006). The growth medium was replaced
twice per week and the day before the experiment. All the
experiments were performed in pre-confluent cultures
and consequently, in nondifferentiated cells. Caco-2 cell
differentiation began when they reached the confluence
and finished after 2 weeks postconfluence, following a
previously described process (Martın-Venegas et al. 2006).
To perform the cell growth assay, cells were harvested
with trypsin/EDTA and passed to 12 mm plastic clusters
at a density of 104 cells/cm2. After 4 days in culture, cells
were incubated with treatments for a period of 48 h.
Then, cell density was around 40 and 80 9 103 cells/cm2
in absence or presence of FBS, respectively. Consequently
all experiments were performed before reaching cell con-
fluence. Cells were then washed, trypsinized, and counted
with a microscope using ethidium bromide/acridine
orange staining to view the number of viable cells (Parks
et al. 1979).
Analysis of DNA synthesis
DNA synthesis was measured using a [3H]thymidine
incorporation assay. Caco-2 cell cultures were kept on 24-
well plates in DMEM with 10% FBS at a density of
104 cells/cm2. After 4 days in culture, the cells were incu-
bated for 48 h with the treatments; [3H]thymidine
(0.1 lCi/well) was added for the last 24 h. The media
containing [3H]thymidine were then aspirated and cells
were washed, overlaid with 1% Triton X-100 and scraped
off the wells (Cabral et al. 2013). Finally, radioactivity
present in the cell fraction was measured by scintillation
counting, using a Packard Tri-Carb 1500 counter (Down-
ers Grove, IL).
Prostaglandin E2 (PGE2) analysis by enzyme
immunoassay
PGE2 determination was performed using a competitive
EIA kit (Cayman, Ann Arbor, MI) following the manufac-
turer’s instructions. Briefly, following a previously described
process cells were maintained in 12 mm plastic clusters at
a density of 104 cells/well (Cabral et al. 2013). After 4 days
in culture, Caco-2 cells were incubated for 60 min at 37°C
with LTD4 (10 nmol/L) in the absence or presence of Cys-
LT1R antagonists or a COX inhibitor. Finally supernatants
were harvested and PGE2 was determined.
Incorporation and release of [3H]AA
Cells were harvested with trypsin/EDTA and passed to 24-
well plates at a density of 104 cells/cm2. After 4 days, cells
were FBS starvated during 24 h and then the medium was
replaced by 0.5 mL DMEM containing 0.1% fatty acid free
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BSA and 0.1 lCi [3H]AA (1 nmol/L) for a period of 6 h.
Cells were then washed three times with 0.5% BSA-con-
taining medium to remove any unincorporated [3H]AA.
After the study period (2 h), the medium was removed to
determine the amount of [3H] radioactivity release. The
amount of [3H]AA released into the medium was
expressed as a percentage of cell-incorporated [3H]AA,
which was determined in solubilized cells, as previously
described (Martın-Venegas et al. 2006).
Western blot analysis
Cells were seeded in 60 mm plastic clusters (104 cells/
cm2) and after 4 days the cultures were washed twice with
ice-cold PBS, scraped off into PBS containing 2 mmol/L
sodium EDTA and pelleted. These pellets were sonicated
in PBS containing 4 mmol/L sodium EDTA, 500 lg/mL
aprotinin, 500 lg/mL leupeptin, 500 lg/mL PMSF, and
400 lg/mL diethyldithiocarbamic acid, then resuspended
in a lysis buffer containing 200 mmol/L Tris-HCl,
200 mmol/L NaCl, 2% Igepal CA-630 and 200 lmol/L
DTT. Finally, an immunoblot analysis for COX-2 was
performed, as previously described (Martın-Venegas et al.
2006). For b-actin immunoblotting, the monoclonal actin
antibody (1:500) was used (Santa Cruz, Dallas, TX).
Measurement of the cell signaling activated
by eicosanoids
Cells were seeded in 60 mm plastic clusters (104 cells/cm2)
and after 4 days the cultures were incubated with the treat-
ments (5 or 15 min) as previously described (Cabral et al.
2013). To measure the kinase activity with total cell lysates,
Caco-2 cells were lysed using a denaturing cell lysis buffer
containing 6 mol/L urea and protease (leupeptin 2 lg/mL,
pepstatin 10 lmol/L, aprotinin 3 lg/mL) and phosphatase
(NaF 5 mmol/L, Na4P2O7 2 mmol/L, Na3VO4 1 mmol/L)
inhibitors. The resulting solutions containing 80–100 lg of
proteins were then added to kinase ELISA plate and the
assay was performed, following the manufacturer’s instruc-
tions (Symansis, Auckland, New Zealand). Optical density
was then measured at 450 nm using a TECAN absorbance
reader (Tecan Austria Gmbh, Salzburg, Austria). This
simultaneous assay for the activation of multiple kinases
provides a qualitatively better alternative to western blot-
ting. We studied the effect of eicosanoids on the phosphor-
ylation of Akt1 (pS473), Akt2 (pS474), ERK1/2 (pT202/
Y204; pT185/Y187), GSK3b (pS9), p38a (pT180/Y182) and
CREB (pS133) on the dephosphorylation of b-catenin (DP
S33/S37/S41). The phosphorylation of Akt, ERK and p38
was measured after 5 min incubation with LTD4, whereas
the phosphorylation of CREB, GSK and the dephosphory-
lation of b-catenin was assayed after 15 min.
Statistical analysis
Results are expressed as mean  SEM. All data were
compared by one-way ANOVA and Student’s t-test using
SPSS software (SPSS Inc., Chicago, IL). P < 0.05 was con-
sidered to denote significance.
Results
Figure 1 shows that LTD4 (1–100 nmol/L) increases the
number of viable cells in Caco-2 cell cultures in compari-
son with the results obtained in the absence of any
growth factor. We note that the effect induced by LTD4
(10 nmol/L) was reduced in the presence of CysLT1R
antagonists (MK 571 and LY 171883), a COX inhibitor
(ketoprofen), a specific COX-2 inhibitor (NS 398), and
EP1 or EP4 antagonists (SC 19220 and AH 23848, respec-
tively) (Fig. 1), whereas the effect of specific COX-1
inhibitor (SC 560) did not reach significance. The men-
tioned treatments did not cause cell detachment nor a
decrease in cell viability at the concentrations tested, as
confirmed by microscopic observation (data not shown).
Figure. 1. The effect of Leukotriene D4 (LTD4) on Caco-2 cell
growth. Cells were incubated for 48 h in the presence of LD4
(1–100 nmol/L) and in the absence of growth factors (FBS); cells
were then counted. Cell growth in control conditions (in the
absence or presence of FBS) was included. LTD4 (10 nmol/L) was
incubated in the presence of MK 571 (MK5, 25 lmol/L), LY171883
(LY1, 25 lmol/L), ketoprofen (Kp, 5 lmol/L), SC 560 (SC5,
60 nmol/L), NS 398 (NS, 5 lmol/L), SC 19220 (SC1, 60 nmol/L) or
AH 23838 (AH, 20 nmol/L). Results are expressed as mean  SEM
of 4-5 determinations performed in triplicate. *P < 0.05 versus
Caco-2 cells cultured without FBS; /P < 0.05 versus Caco-2 cells
cultured with FBS; #P < 0.05 versus Caco-2 cells cultured with LTD4
(10 nmol/L).
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The mitogenic effect observed with LTD4 was con-
firmed using [3H]thymidine incorporation (Fig. 2). We
found that LTD4 (10 nmol/L) induced DNA synthesis,
whereas the above mentioned CysLT1R antagonists
(i.e., MK 571 and LY 171883), the COX inhibitors, and
the EP antagonists significantly inhibited the incorpora-
tion of [3H]thymidine into Caco-2 cells induced by
LTD4.
LTD4 (10 nmol/L) was also able to induce a significant
release of [3H]AA by Caco-2 cells, which was blocked in
the presence of CystLT1R antagonists (MK 571 and LY
171883) (Table 1). Moreover, the release of [3H]AA
induced by LTD4 was blocked by a number of inhibitors:
a PLC inhibitor (U 73122); an inhibitor that prevents the
release of calcium from the endoplasmic reticulum (dan-
trolene), and by a PKC inhibitor (G€o 6983). We observed
that the release of [3H]AA induced by LTD4 was also
inhibited by a nonspecific phospholipase A2 (PLA2) inhib-
itor (AACOCF3) but not by a specific calcium-indepen-
dent PLA2 inhibitor, for example, BEL. In addition, our
study showed that LTD4 (10 nmol/L) increases the
expression of COX-2, and that this effect was reverted by
a CysLT1R antagonist (Fig. 3A). In addition, we found
that LTD4 induced the synthesis of PGE2 and that this
action was reverted by CystLT1R antagonists (MK 571
and LY 171883) and ketoprofen (Fig. 3B).
Finally, we studied the capacity of LTD4 to phosphory-
late pivotal elements in the cell signaling pathways impli-
cated in the regulation of cell growth. For ERK,
phosphorylation was highest after 5 min incubation and
for CREB after 15 min. Dephosphorylation of b-catenin
also increased after 15 min incubation (Fig. 4A). In addi-
tion, our results show that ERK phosphorylation induced
by LTD4 was reverted by a CysLT1R antagonist as well as
by a COX inhibitor (Fig. 4B) and that CREB phosphory-
lation induced by LTD4 was also blocked by ketoprofen
(Fig. 4B).
Discussion
Colorectal cancer is the third most common cancer in the
Western world and almost half of patients die of meta-
static disease. This highlights the importance of research
into the molecular mechanisms involved and their role in
prognosis. Previous findings in our laboratory have dem-
onstrated that the release of AA by PLA2s participates in
the signaling pathways involved in the control of intesti-
nal epithelial cell proliferation (Sanchez and Moreno
2002a), and that its subsequent metabolism by COX-2
could be involved in the control of Caco-2 cell growth.
Research has shown that in tumor tissue, COX and 5-
LOX pathways are upregulated, which is not seen in nor-
mal colon mucosa (Cianchi et al. 2006). Moreover, as
Cianchi et al. (2006) reported, 5-LOX inhibition increases
the antitumor activity of COX inhibitors in human colon
cancer cells. These findings support the hypothesis that
Figure 2. The effect of Leukotriene D4 (LTD4) on DNA synthesis.
Caco-2 cells were incubated for 48 h in the presence of LTD4
(10 nmol/L) and in the absence of growth factors (FBS); [3H]
thymidine incorporation into cells was then measured. DNA
synthesis in control conditions (in the absence or presence of FBS)
was included. LTD4 (10 nmol/L) was incubated in the presence of
MK 571 (MK5, 25 lmol/L), LY171883 (LY1, 25 lmol/L), ketoprofen
(Kp, 5 lmol/L), SC 560 (SC5, 60 nmol/L), NS 398 (NS, 5 lmol/L),
SC 19220 (SC1, 60 nmol/L) or AH 23838 (AH, 20 nmol/L). Results
are expressed as mean  SEM of 4–5 determinations performed in
triplicate. *P < 0.05 versus Caco-2 cells cultured without FBS;
/P < 0.05 versus Caco-2 cells cultured with FBS; #P < 0.05 versus
Caco-2 cells cultured with LTD4.
Table 1. [3H]AA release induced by leukotriene D4 (LTD4).
[3H]AA (%)
Control 4.1  0.3
LTD4 23.6  1.8*
LTD4 + AACOCF3 (10 lmol/L) 8.2  0.7*,#
LTD4 + BEL (10 lmol/L) 21.3  1.7*
LTD4 + MK 571 (25 lmol/L) 7.2  1.1#
LTD4 + LY 171883 (25 lmol/L) 7.9  1.5#
LTD4 + U 73122 (0.1 lmol/L) 11.5  2.1*,#
LTD4 + Dantrolene (50 lmol/L) 12.6  1.8*,#
LTD4 + G€o 6983 (1 lmol/L) 13.4  1.3*,#
[3H]AA was determined in non-differentiated Caco-2 cell cultures,
as described in the Materials and Methods section. Cells were
incubated in the presence of LTD4 (10 nmol/L) or LTD4 plus treat-
ments and [3H]AA was determined 30 min after LTD4 incubation,
respectively. Values are means  SEM of three experiments per-
formed in triplicate, *P < 0.05 versus control; #P < 0.05 versus
LTD4.
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the key elements of the AA cascade are involved in the
regulation of intestinal epithelial structure/function (Fer-
rer and Moreno 2010).
Recently, we reported that pre-confluent Caco-2 cells
were able to synthesize LTB4 and 5-, and 12- and 15-
HETE eicosanoids, which were found to be involved in
the regulation of Caco-2 cell growth (Cabral et al. 2013).
Dreyling et al. (1986) reported that human gastrointesti-
nal tissues could synthesize cysteinyl leukotrienes, how-
ever, we were unable to detect LTD4 in Caco-2 cell
culture supernatants (Cabral et al. 2013). Paruchuri et al.
(2006) reported that cysteinyl LTs released from Caco-2
A
B
Figure 3. The effect of Leukotriene D4 (LTD4) on COX-2 expression
and PGE2 synthesis. (A) Cells were incubated in the absence of FBS
(Control) and in the presence of LTD4 (10 nmol/L) or LTD4 plus
LY171883 (LY1, 25 lmol/L) for 30 min and COX-2 expression was
determined using a specific antibody. Murine COX-2 (20 ng) was
used as standard (St COX-2). Western blot was used in three
experiments. (B) Caco-2 cells were incubated with LTD4
(1–100 nmol/L) for 15 min and PGE2 synthesis was determined.
PGE2 synthesis induced by LTD4 (10 nmol/L) was studied in the
presence of MK 571 (MK5, 25 lmol/L), LY171883 (LY1, 25 lmol/L)
or ketoprofen (Kp, 5 lmol/L). Results are expressed in mean  SEM
of 5 determinations performed in triplicate. *P < 0.05 versus
Caco-2 cell cultures in the absence of growth factors (FBS);
#P < 0.05 versus cells incubated with LTD4 (10 nmol/L).
A
B
Figure 4. The effect of Leukotriene D4 (LTD4) on cell signaling. (A)
Caco-2 cells were incubated with LTD4 (10 nmol/L) for 5 or 15 min
and then cells were collected. Phosphorylated Akt1, Akt2, ERK1/2,
p38a, CREB, and GSKb and dephosphorylated b-catenin were then
measured, as described in the Material and Methods section. (B)
The effect of LTD4 (10 nmol/L) on ERK1/2 and CREB pathways.
Cells were incubated with LTD4 (10 nmol/L) for 5 min in the
presence of LY171883 (LY1, 25 lmol/L) or ketoprofen (Kp, 5 lmol/L).
Values are mean  SEM of triplicate determinations, the
experiment was repeated twice. *P < 0.05 versus Caco-2 cells
cultures in the absence of LTD4 (10 nmol/L);
#P < 0.05 versus cells
incubated with LTD4 (10 nmol/L).
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cells reached a concentration of 5 pmol/L, which is nota-
bly lower than the limits of detection (0.3 mmol/L) for
this eicosanoid in our experimental conditions (Martın-
Venegas et al. 2011).
It is important to consider that the tumor microenvi-
ronment has often been associated with infiltrating leu-
kocytes in the tumor tissue and the surrounding stroma
(Negus et al. 1997). Consequently, the activation of mac-
rophages and mast cells in inflammatory processes and
cancer might induce an additional release of cysteinyl
LTs, such as LTD4, in the intestinal mucosa. Thus, our
findings demonstrate that at a concentration range of 1–
100 nmol/L, which is a level likely reached under tumor-
igenic conditions, LTD4 can induce Caco-2 cell prolifera-
tion and DNA synthesis. Moreover, our results have
confirmed, using specific receptorial antagonists, that
this effect is a consequence of the interaction with Cys-
tLT1R.
This effect was also reported by Magnusson et al.
(2007), who demonstrated that unlike CysLT2R, CysLT1R
is involved in intestinal epithelial proliferation. Moreover,
it has been described that this receptor is upregulated in
colon cancer and correlates with a poorer prognosis (€Ohd
et al. 2003; Magnusson et al. 2010). Similarly, we recently
reported that the LTD4-CystLT1R interaction increases
intracellular Ca2+ concentrations in Caco-2 cells, indicat-
ing that PLC activation as well as stores of extracellular
Ca2+ and intracellular Ca2+ are involved in this event
(Rodrıguez-Lagunas et al. 2013). Our results indicate that
the PLC-IP3-Ca
2+/DAG-PKC signaling pathways and
cytosolic PLA2 participate in the release of [
3H]AA
induced by the LTD4-CystLT1R interaction. Consequently
this also demonstrates their participation in the activation
of the AA cascade and eicosanoid production. These find-
ings are consistent with Parhamifar et al. (2005) who
reported that cytosolic PLA2 was activated and translocat-
ed to the nucleus upon LTD4 stimulation via a Ca
2+-
dependent mechanism that involves the activation of PKC
in Caco-2 cells.
Furthermore, we observed that the interaction of LTD4
with the CystL1T receptor stimulated COX-2 expression,
which is consistent with previous research, carried out by
Yudina et al. (2008) using different intestinal epithelial
cells. We can therefore surmise that PGE2 synthesis was
induced by LTD4, which is consistent with the results
obtained by €Ohd et al. (2000) and Massoumi et al.
(2003). Given that Caco-2 cell proliferation induced by
LTD4 was reverted by nonspecific and specific COX
inhibitors as well as EP1 and EP4 antagonists, we propose
that this action is completely dependent of PGE2 synthe-
sized by both COX as well as by PGE2 interaction with
EP1 and EP4 that stimulated cell signaling pathways that
are crucial in the progression of the cell cycle as previ-
ously described in our group (Cabral et al. 2013; Sanchez
and Moreno 2002b). Thus, [3H]AA release, metabolism
by both COXs, and the interaction of PGE2 with EP1 and
EP4 receptors are not only important events of acute and
chronic inflammation, but are also essential regulators of
the proliferation of transformed intestinal epithelial can-
cer cells induced by LTD4.
We recently demonstrated the signaling pathways
involved in Caco-2 cell growth induced by PGE2 to be
ERK, CREB, GSK, and p38, which is consistent with
Pham et al. (2008) and Cherukuri et al. (2007). Our
results also indicate that LTD4 also induces ERK and
CREB phosphorylation and that both signaling pathways
were completely blocked when COX was inhibited. This
therefore indicates that the activation of both ERK and
CREB could be attributed to PGE2 synthesis induced by
LTD4. Furthermore, while Caco-2 cells have a high basal
b-catenin dephosphorylation level, we found that LTD4
induces an additional dephosphorylation, which is consis-
tent with research by €Ohd et al. (2000). A previous study
on Caco-2 cells in our laboratory revealed that this signal-
ing pathway was not activated by a mitogenic factor such
as PGE2. Thus, since the mitogenic effect of LTD4 is com-
pletely PGE2-dependent, it is unlikely that the activation
of the b-catenin pathway by LTD4 is directly related to
cell proliferation, and so as reported by Salim et al.
(2014), the dephosphorylation of b-catenin induced by
LTD4 could be linked to the migration of colon cancer
cells.
In conclusion, the effects of LTD4 appear to occur
through the increased expression and activation of COX-
2, the production of PGE2, and the interaction of PGE2
with its cell-surface receptors. These findings will help
improve our understanding of how inflammatory media-
tors can affect the survival and dissemination of intestinal
carcinoma cells.
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